3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Active not recruiting
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Overweight
1
Obesity
1
Neoplasms
1
Motor Activity
1
Metabolic Diseases
1
Hypertension
1
Hypercholesterolemia
1
Heart Diseases
1
Diabetes Mellitus, Type 2
1
Cardiovascular Diseases
1
Advanced Malignant Solid Neoplasm
1
Interventions
Exercise
34
Nutritional Status
5
Control Groups
4
Resistance Training
3
High-Intensity Interval Training
3
lime
2
Vitamin D
2
Standard of Care
2
Preoperative Exercise
2
Dosage Forms
2
Diet
2
tislelizumab
1
pembrolizumab
1
oncomodulin
1
diacetamate
1
blueberry extract
1
beta-Glucans
1
Whey Proteins
1
Wearable Electronic Devices
1
Walking
1
Transcranial Direct Current Stimulation
1
Tea
1
Tablets
1
TEMPO
1
Spermine Synthase
1
Roflumilast
1
Rehabilitation
1
Probiotics
1
Physical Therapy Modalities
1
Physical Examination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Motor Activity
×
Nutrition Assessment
×
Clear all
NCT07341698
2026-01-29
PrepAllo
Rigshospitalet, Denmark
Phase NA
Recruiting
110 enrolled